Teleflex (TFX) Cash & Equivalents (2009 - 2026)
Teleflex's (TFX) quarterly Cash & Equivalents came in at $309.4 million in Q1 2026, up 8.9% YoY from $284.1 million in Q1 2025, and down 18.27% on a QoQ basis from $378.6 million in Q4 2025.
Teleflex (TFX) Cash & Equivalents (2009 - 2026) Analysis & Trends
Teleflex (TFX) has 18 years of Cash & Equivalents data on file, last reported at $309.4 million in Q1 2026.
- Quarterly Cash & Equivalents rose 8.9% year-over-year to $309.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $309.4 million (up 8.9% YoY) and the FY2025 annual result came in at $378.6 million, up 52.74% from the prior year.
- Cash & Equivalents slipped to $309.4 million in Q1 2026, from $378.6 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $881.5 million in Q4 2023 to a low of $222.8 million in Q4 2023.
- A 5-year average of $331.2 million and a median of $284.1 million in 2025 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2023 — Cash & Equivalents surged 121.9% — and 2024, when it tumbled 72.41%.
- Tracing TFX's Cash & Equivalents over 5 years: stood at $292.0 million in 2022, then retreated by 23.69% to $222.8 million in 2023, then gained by 11.22% to $247.9 million in 2024, then surged by 52.74% to $378.6 million in 2025, then retreated by 18.27% to $309.4 million in 2026.
- The last three Cash & Equivalents figures came in at $309.4 million (Q1 2026), $378.6 million (Q4 2025), and $354.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 2.76 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 708.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 1.36 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.47 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.33 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 403.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 2.15 Bn |
| 10 | Teleflex | 6.03 Bn | 5.73 Bn | 331.71 Mn | 300.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 300.16 Mn |
| Mar 31, 2026 | 309.41 Mn |
| Dec 31, 2025 | 378.56 Mn |
| Sep 28, 2025 | 354.00 Mn |
| Jun 29, 2025 | 253.70 Mn |
| Mar 30, 2025 | 284.12 Mn |
| Dec 31, 2024 | 247.85 Mn |
| Sep 29, 2024 | 243.24 Mn |
| Jun 30, 2024 | 238.57 Mn |
| Mar 31, 2024 | 237.42 Mn |
| Dec 31, 2023 | 222.85 Mn |
| Oct 1, 2023 | 881.50 Mn |
| Jul 2, 2023 | 250.82 Mn |
| Apr 2, 2023 | 264.14 Mn |
| Dec 31, 2022 | 292.03 Mn |
| Sep 25, 2022 | 397.26 Mn |
| Jun 26, 2022 | 308.12 Mn |
| Mar 27, 2022 | 466.66 Mn |
| Dec 31, 2021 | 445.08 Mn |
| Sep 26, 2021 | 481.17 Mn |